Target intelligence / Profile preview

Brain extracellular matrix proteins and remodeling enzymes (Brain ECM)

Target
Brain ECM
Molecular classification
Enzyme, Proteoglycan, Glycoprotein, Structural protein
01

Overview

The brain extracellular matrix (ECM) is a specialized network of macromolecules, including proteoglycans, glycoproteins, and glycosaminoglycans, that occupies the space between neural cells. Unlike the fibrous ECM in peripheral tissues, the brain ECM is rich in hyaluronic acid and lecticans, often forming condensed structures known as perineuronal nets that stabilize adult synapses and restrict plasticity (Dityatev et al., 2010, Nature Reviews Neuroscience). Remodeling enzymes, such as matrix metalloproteinases (MMPs) and ADAMTS proteases, are responsible for the dynamic turnover of these components, a process essential for learning, memory, and recovery from injury (Bonneh-Barkay & Wiley, 2009, Brain Pathology). Dysregulation of this balance is a hallmark of several neurological conditions; for instance, excessive MMP activity contributes to blood-brain barrier breakdown in stroke, while the accumulation of inhibitory proteoglycans prevents axonal regeneration after spinal cord injury (Lau et al., 2013, Nature Reviews Neuroscience). Pharmacological interventions typically aim to either inhibit degradative enzymes to preserve tissue integrity or utilize exogenous enzymes like chondroitinase ABC to dissolve inhibitory scars and restore functional plasticity (Zimmermann & Dours-Zimmermann, 2008, Histochemistry and Cell Biology).

Other names
Neural extracellular matrixPerineuronal netsCNS extracellular matrixBrain ECM
02

Mechanism of action

Inhibition of matrix metalloproteinases (MMPs) to prevent tissue degradation; Enzymatic digestion of chondroitin sulfate proteoglycans to promote plasticity; Modulation of integrin-mediated signaling.

03

Biological functions

Synaptic plasticityAxonal guidanceCell migrationStructural supportBlood-brain barrier integrityNeurogenesis
04

Disease associations

Alzheimer's diseaseEpilepsyGlioblastomaStrokeMultiple sclerosisSpinal cord injurySchizophrenia
05

Safety considerations

Off-target systemic effects of broad-spectrum MMP inhibitorsDisruption of normal synaptic pruning and connectivityPotential for blood-brain barrier leakageMusculoskeletal syndrome associated with chronic ECM modulation
06

Interacting drugs

Minocycline

4 more in the full profile.

07

Biomarkers

MMP-9 levelsHyaluronic acid concentrationNeurocan fragmentsTenascin-C expression

Beyond the preview

Go deeper on Brain extracellular matrix proteins and remodeling enzymes (Brain ECM).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Brain extracellular matrix proteins and remodeling enzymes (Brain ECM).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call